Longevity UnmaskedLongevity Unmasked

Question 272 of 433

Should a healthy person take a GLP-1 medicine for longevity?

Evidence grade (draft mapping)FNot demonstrated / insufficientARobust human trials
Weekly pill organizer on a sunny kitchen counter

The short answer

If you have obesity, diabetes, or heart disease, these drugs extend healthy life and probably life itself. If you are lean and well, there is no trial to support it.

Semaglutide reduced heart attacks, strokes, and cardiac death by 20 percent in people with obesity and heart disease, slowed kidney failure, and improved heart failure, sleep apnea, and fatty liver. Those are longevity outcomes by any definition.

For healthy people, the “microdose” approach is unproven, and the costs are certain: possible lean-tissue loss, which includes more than skeletal muscle, and a need to protect nutrition and function, stomach side effects, expense, and probable weight regain on stopping. The largest trial in early Alzheimer’s disease was negative. See Part 11 for the details.

“This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship.” From the book’s medical disclaimer. Full disclaimer

Evidence scope
ROBUST in specific obesity, diabetes, or cardiovascular-risk populations; NOT DEMONSTRATED for lean healthy microdosing.Evidence grade (draft mapping)FNot demonstrated / insufficientARobust human trialsPart 19, Q272 · Sources: R3

Sources cited

All of Part 19

Related questions